Influence of PARAmedical Interventions on Patient ACTivation in the Cancer Care Pathway

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

600 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-01-28

Study Completion Date

2022-10-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim is to implement the Patient Activation Measure in paramedical practices as a tool to measure activation of patients in cancer care

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Ambulatory Measurement of Physical Activity in Pancreatic Cancer Patients

NCT03490604

Unresectable Pancreatic Adenocarcinoma

COMPLETED

Patient Activation Through Counseling, Exercise and Mobilization

NCT03411200

Pancreas Cancer Biliary Tract Cancer Non Small Cell Lung Cancer +1 more

COMPLETED NA

Behavioral Activation-Led Activity Engagement for Cancer Empowerment

NCT06796608

Advanced Cancer Cancer

COMPLETED NA

Interventional Study on DEterminants and Factors of Physical ACtivity After Treatments in Oncology

NCT05354882

Breast Cancer Colo-rectal Cancer Lung Cancer +1 more

UNKNOWN NA

Impact of Personalized and Remote Support Centered on Exercise and Physical Activity for Breast Cancer Patients

NCT04536584

Breast Cancer Female

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient Activation Measure (PAM)

completion of the PAM questionnaire

Group Type EXPERIMENTAL

Patient Activation Measure Questionnaire

Intervention Type BEHAVIORAL

Measure the level of patient engagement in cancer care pathway

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Patient Activation Measure Questionnaire

Measure the level of patient engagement in cancer care pathway

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age over 18 years
* Cancer patient with an estimated life expectancy of at least one year
* Patient requiring immunotherapy or intravenous chemotherapy for any cancer according to the decision of the Multidisciplinary Consultation Meeting
* Patient affiliated or entitled to a social security scheme

Exclusion Criteria

* Refusal to participate, protected adult patient under guardianship.
* Patient disability to understand the course of the study
* Patient with documented history of cognitive or psychiatric disorders.
* Patient not understanding French

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No